Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 2, 2011
HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patientsMan Li, Xue-Hua Sun, Xiao-Jun Zhu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 13, 2016
Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistenceMan Li, Zhen-Hua Zhou, Xue-Hua Sun, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 20, 2018
Beneficial Effects of Bushen Formula Combined with Enticavir on Chronic Hepatitis B Patients with Suboptimal Response to Enticavir by Regulating B-Cell DifferentiationMan Li, Zhen-Hua Zhou, Ting Bao, et al.
Hepatology International|March 1, 2016
The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infectionMan Li, Zhen-Hua Zhou, Xue-Hua Sun, et al.
Journal of Immunology Research|August 9, 2020
Mechanism of Follicular Helper T Cell Differentiation Regulated by Transcription FactorsLong-Shan Ji, Xue-Hua Sun, Xin Zhang, et al.
Journal of Immunology Research|February 16, 2019
Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B PatientsLong-Shan Ji, Qiu-Tian Gao, Ruo-Wen Guo, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 20, 2019
Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled TrialJing-Hao Zhang, Chao Zheng, Xiao-Jun Zhu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|August 25, 2020
Long-Term Traditional Chinese Medicine Combined with NA Antiviral Therapy on Cirrhosis Incidence in Chronic Hepatitis B Patients in the Real-World Setting: A Retrospective StudyZhi-Jun Hou, Jing-Hao Zhang, Xin Zhang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 4, 2022
Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialJing-Hao Zhang, Xin Zhang, Zhen-Hua Zhou, et al.
Pageof 3